<p><strong>Hawkins</strong> (NASDAQ:HWKN) is set to give its latest quarterly earnings report on Wednesday, 2026-01-28. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Hawkins will report an <strong>earnings per share</strong> (EPS) of $0.73. </p>
<p>The market awaits Hawkins's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS missed by $0.15 in the last quarter, leading to a 5.04% drop in the share price on the following day.</p>
<p>Here's a look at Hawkins's past performance and the resulting price change:</p>
<p></p><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q2 2026</strong></th>
<th align="right"><strong>Q1 2026</strong></th>
<th align="right"><strong>Q4 2025</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">1.23</td>
<td align="right">1.34</td>
<td align="right">0.75</td>
<td align="right">0.92</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">1.08</td>
<td align="right">1.40</td>
<td align="right">0.78</td>
<td align="right">0.72</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-5.00</td>
<td align="right">3.00</td>
<td align="right">-1.00</td>
<td align="right">-8.00</td>
</tr>
</tbody>
</table><p></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769536875_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769536875_0.png"/></p>

<h3>Performance of Hawkins Shares</h3>
<p>Shares of Hawkins were trading at $153.23 as of January 26. Over the last 52-week period, shares are up 31.31%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Hawkins</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Hawkins.</p>
<p>The consensus rating for Hawkins is Buy, derived from 1 analyst ratings. An average one-year price target of $200.0 implies a potential 30.52% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Olin, Cabot and Tronox Holdings, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Olin, with an average 1-year price target of $23.22, suggesting a potential 84.85% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Cabot, with an average 1-year price target of $69.0, suggesting a potential 54.97% downside.</li>
<li>Analysts currently favor an Buy trajectory for Tronox Holdings, with an average 1-year price target of $4.67, suggesting a potential 96.95% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Olin, Cabot and Tronox Holdings, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p></p><table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hawkins</td>
<td>Buy</td>
<td>13.52%</td>
<td>$67.64M</td>
<td>4.56%</td>
</tr>
<tr>
<td>Olin</td>
<td>Neutral</td>
<td>7.78%</td>
<td>$183.40M</td>
<td>2.18%</td>
</tr>
<tr>
<td>Cabot</td>
<td>Neutral</td>
<td>-10.19%</td>
<td>$220M</td>
<td>2.72%</td>
</tr>
<tr>
<td>Tronox Holdings</td>
<td>Buy</td>
<td>-13.06%</td>
<td>$52M</td>
<td>-6.17%</td>
</tr>
</tbody>
</table><p></p>
<p>Key Takeaway:</p>
<p>Hawkins ranks highest in revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity.</p>
<h3>Discovering Hawkins: A Closer Look</h3>
<p>Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.</p>
<h3>Unraveling the Financial Story of Hawkins</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Hawkins displayed positive results in 3 months. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately <strong>13.52%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Hawkins's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>8.06%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Hawkins's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>4.56%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Hawkins's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.29%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Hawkins's debt-to-equity ratio is below the industry average. With a ratio of <b>0.58</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p>To track all earnings releases for Hawkins visit their earnings calendar on our site.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>

HWKN

<p>Hawkins (NASDAQ:HWKN) will report its quarterly earnings on January 28, 2026, with analysts estimating an EPS of $0.73. The company previously missed EPS estimates, causing a 5.04% drop in share price. Currently trading at $153.23, Hawkins shares have risen 31.31% over the past year. Analysts rate Hawkins as a Buy, with a one-year price target of $200. Hawkins leads its peers in revenue growth at 13.52% and has a strong net margin of 8.06%, although its return on equity is lower than industry averages. The company operates in chemicals and ingredients across three segments.</p>

A Look Ahead: Hawkins's Earnings Forecast